Schizophrenia Care: Improving Social Cognition and Motivation
Michael Green, PhD
PeerThe Evolving gMG Treatment Landscape
Henry Kaminski, MD
PeerFcRn Inhibitors: A Potential New Targeted Therapy Option
Nicholas J. Silvestri, MD, FAAN
PeerEarly Alzheimer’s Disease Treatment: Assessing Patients and Coordinating Care
Advancements in Understanding ALS Treatment
From Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Investigating a gMG Therapy, Part 1: The MG-ADL Results
Christyn Edmundson, MD
PeerInvestigating a gMG Therapy, Part 2: The Secondary Endpoint Results, Including MG Symptoms PRO
Christyn Edmundson, MD
PeerInvestigating a gMG Therapy, Part 3: Results from the Extension Studies
Christyn Edmundson, MD
Peer